Showing results (281-290 of 296) with videos related to

Sort By:
Pageof 30
Gastroenterology|October 27, 2015
Effectiveness of Simeprevir Plus Sofosbuvir, With or Without Ribavirin, in Real-World Patients With HCV Genotype 1 InfectionMark S Sulkowski, Hugo E Vargas, Adrian M Di Bisceglie, et al.
Hepatology (Baltimore, Md.)|September 16, 2020
Low Incidence of Adverse Outcomes in Adults With Chronic Hepatitis B Virus Infection in the Era of Antiviral TherapyAnna S Lok, Robert Perrillo, Christina M Lalama, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 7, 2018
Safety and Effectiveness of Ledipasvir and Sofosbuvir, With or Without Ribavirin, in Treatment-Experienced Patients With Genotype 1 Hepatitis C Virus Infection and CirrhosisJoseph K Lim, Ann Marie Liapakis, Mitchell L Shiffman, et al.
Hepatology Communications|November 6, 2023
Patient-reported symptoms and interest in symptom monitoring in HCC treated with locoregional therapies: A qualitative studyAndrew M Moon, Sarah Cook, Rachel M Swier, et al.
Hepatology (Baltimore, Md.)|November 21, 2017
Glecaprevir/Pibrentasvir in patients with hepatitis C virus genotype 1 or 4 and past direct-acting antiviral treatment failureFred Poordad, Stanislas Pol, Armen Asatryan, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|January 27, 2017
Ledipasvir-sofosbuvir and sofosbuvir plus ribavirin in patients with chronic hepatitis C and bleeding disordersC E Walsh, K Workowski, N A Terrault, et al.
Alimentary Pharmacology & Therapeutics|October 30, 2016
All-oral direct-acting antiviral therapy in HCV-advanced liver disease is effective in real-world practice: observations through HCV-TARGET databaseK R Reddy, J K Lim, A Kuo, et al.
Gastroenterology|August 12, 2019
Efficacy of Glecaprevir and Pibrentasvir in Patients With Genotype 1 Hepatitis C Virus Infection With Treatment Failure After NS5A Inhibitor Plus Sofosbuvir TherapyAnna S Lok, Mark S Sulkowski, Jens J Kort, et al.
Hepatology (Baltimore, Md.)|December 4, 2024
Hepatic real-world outcomes with obeticholic acid in primary biliary cholangitis (HEROES): A trial emulation study designM Alan Brookhart, Tracy J Mayne, Charles Coombs, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 11, 2014
Characteristics of adults in the hepatitis B research network in North America reflect their country of origin and hepatitis B virus genotypeMarc G Ghany, Robert Perrillo, Ruosha Li, et al.
Pageof 30